Home News Medtech

Hyphens Pharma awarded e-pharmacy licence for WellAway Pharmacy

Felicia Tan
Felicia Tan1/7/2021 07:38 PM GMT+08  • 1 min read
Hyphens Pharma awarded e-pharmacy licence for WellAway Pharmacy
Shares in Hyphens Pharma closed 1 cent higher or 3.2% up at 32.5 cents on Jan 7.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Hyphens Pharma announced on Jan 7, that its subsidiary, Pan-Malayan Pharmaceuticals has been awarded with an e-pharmacy licence for WellAway Pharmacy by the Health Sciences Authority (HSA).

WellAway Pharmacy aims to leverage on Pan-Malayan’s medical and logistical expertise, to work closely with medical clinics in Singapore in providing reliable and convenient medication delivery services to residential homes.

“With the rise of telemedicine redefining healthcare systems all over the world, e-pharmacy and home delivery services have become increasingly important to ensure that patients receive essential medications on time. We hope WellAway will contribute to the evolving development of telemedicine in Singapore,” says Lim See Wah, executive officer and CEO of Hyphens Pharma.

Shares in Hyphens Pharma closed 1 cent higher or 3.2% up at 32.5 cents on Jan 7.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.